Although the future is exciting, it also poses real challenges. More collaborative initiatives need to take place between drug manufacturers and developers of manufacturing equipment and consumables.
As more healthcare activities take place from home, passive continuous monitoring solutions and new technology such as artificial intelligence will be critical to communications between providers and patients. In addition, new solutions that offer overnight monitoring will play a crucial role in helping to fill the gaps, particularly in assessing patient deterioration or changes in health conditions. The pandemic has forever changed the trajectory of healthcare and specifically virtual care.
The omicron variant of the coronavirus has made clear that the impact of the pandemic is far from over, particularly for health systems and hospitals. The ongoing need to limit close contact between providers and patients means technology will continue to play a key role, but with that increased reliance on technology comes the heightened exposure to cyber risks, as well.
The test detects all known variants of SARS-CoV-2, including alpha, beta, gamma and omicron.
With COVID-19 vaccines in mind, Georgia Tech and Emory University researchers have developed a delivery device that could significantly improve vaccine immune response.
Clinical Trials Labeling and Regulated Content Management Added to Cloud-Based Platform
Although many elective procedures were canceled during the course of the pandemic, the market has not been negatively affected.
Increased use of remote and telehealth programs, networked medical devices, and “smart” product storage come with their own inherent risks.
Keeping temperature-sensitive medical products within the required levels is vital in today’s world, especially as supply-chain issues are making transportation challenging. Monitoring equipment will ensure items stay safe as they move from the device manufacturer to consumer.
The center is also hoping to move back into more normal review timelines next year.